ClearPoint Neuro (CLPT) Operating Leases (2019 - 2026)

ClearPoint Neuro's Operating Leases history runs 8 years deep, the most recent figure standing at $13.7 million for Q1 2026.

• In Q1 2026, Operating Leases rose 379.37% year-over-year to $13.7 million; the TTM figure through Mar 2026 stood at $13.7 million (up 379.37% YoY), while the FY2025 annual figure was $8.5 million, up 181.0% from the prior year.
• Operating Leases came in at $13.7 million for Q1 2026 at ClearPoint Neuro, up from $8.5 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $13.7 million in Q1 2026 to a low of $1.4 million in Q1 2023.
• A 5-year average of $4.1 million and a median of $3.3 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases decreased 25.88% in 2022 and soared 379.37% in 2026, its largest moves.
• ClearPoint Neuro's Operating Leases stood at $1.5 million in 2022, then soared by 132.9% to $3.6 million in 2023, then slipped by 15.61% to $3.0 million in 2024, then soared by 181.0% to $8.5 million in 2025, then soared by 62.04% to $13.7 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $13.7 million, $8.5 million, and $6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison